Epigenetic reprogramming startup identifies mult
Author: Michael
New RNAi therapeutic offers a novel mechanism to
Startup aims for clinical trials of microglia-ta
Study suggests anti-amyloid treatment may halve
Elevant’s best-selling biohacking product prov
Company to initiate clinical study of gene-silen
Sens.
Portuguese defender invests more than €1 milli
Longevity startup offers AI-powered blood biomar
New research finds that endothelial TDP-43 loss